LEADER 01936nam  2200493 a 450 
001 9910697157403321
005 20230902161716.0
035   $a(CKB)5470000002385337
035   $a(OCoLC)708361533
035   $a(EXLCZ)995470000002385337
100   $a20110324d2010      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFalse carbamazepine positives due to 10,11-dihydro-10-hydroxycarbamazepine breakdown in the GC/MS injector port$b[electronic resource] /$fRobert D. Johnson, Russell J. Lewis, and Mike K. Angier
210  1$aWashington, D.C. :$cFederal Aviation Administration, Office of Aerospace Medicine,$d[2010]
215   $a1 online resource (iii, 5 pages)
300   $a"February 2010."
300   $aTitle from title screen (viewed on Mar. 23, 2011).
300   $a"DOT/FAA/AM-10/4."
300   $a"This work was accomplished under the approved task AM-B-05-TOX-204."--P. i.
320   $aIncludes bibliographical references.
606   $aAviation toxicology$xResearch
606   $aForensic toxicology
606   $aAircraft accidents$xInvestigation
606   $aAircraft accidents$xHuman factors
606   $aCarbamazepine$xResearch
615  0$aAviation toxicology$xResearch.
615  0$aForensic toxicology.
615  0$aAircraft accidents$xInvestigation.
615  0$aAircraft accidents$xHuman factors.
615  0$aCarbamazepine$xResearch.
700   $aJohnson$b Robert D$g(Robert David),$f1974-$01382527
701   $aLewis$b Russell J$01382528
701   $aAngier$b Mike K$01384636
712 02$aUnited States.$bOffice of Aerospace Medicine.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697157403321
996   $aFalse carbamazepine positives due to 10,11-dihydro-10-hydroxycarbamazepine breakdown in the GC$93550280
997   $aUNINA